ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaselNoorik Biopharmaceuticals AG
Noorik Biopharmaceuticals AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Noorik Biopharmaceuticals AG is a privately owned drug development company focused on repurposing existing drugs and conducting research and development. It is developing a micro-dose formulation of ambrisentan, an endothelin receptor antagonist, for indications including severe COVID-19 pneumonia, portal hypertension and pulmonary arterial hypertension, and has developed novel oral and parenteral formulations, holds second medical use patents and is seeking co-development partners.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Noorik Biopharmaceuticals AG

✓ Offered1
Oncological precision tools
Precision tools to remodel the tumor microenvironment, to improve target engagement and increase the tumor-specific drug distribution in cancer treatments.
Trust & reputation

ranQ Trust Score of Noorik Biopharmaceuticals AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Noorik Biopharmaceuticals AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Noorik Biopharmaceuticals AG scores 85.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Noorik Biopharmaceuticals AG scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Noorik Biopharmaceuticals AG scores 34.3 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.34.34%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Noorik Biopharmaceuticals AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Noorik Biopharmaceuticals AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Noorik Biopharmaceuticals AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Noorik Biopharmaceuticals AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Noorik Biopharmaceuticals AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Lange Gasse 15
4052 Basel
Opening hours
Mon
08:00 - 17:00
Tue
08:00 - 17:00
Wed
08:00 - 17:00
Thu
08:00 - 17:00
Fri
08:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-115.986.883
Founded
2010 · 16 years
Last commercial register change
August 21, 2026
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    LS
    Latscha Schöllhorn Partner AG
    Basel
    LG
    Lonza Group AG
    Basel
    VA
    Vaximm AG
    Basel
    AA
    Anaveon AG
    Basel
    MP
    Mepha Pharma AG
    Basel
    AA
    Adagene AG
    Basel
    SA
    Solvias AG
    Basel
    CP
    Corden Pharma International Switzerland GmbH
    Basel